Pfizer seeks FDA authorization of vaccine for younger children
Pfizer is looking for Food and Drug Administration authorization of its coronavirus vaccine for children ages 5 to 11. Dr. Jodie Guest, vice chair of the epidemiology department at Rollins School of Public Health at Emory University, joins Tanya Rivero on CBSN to talk about the latest on the United States' vaccination effort.